Interaction between hepatitis B virus and SARS-CoV-2 infections

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A novel coronavirus outbreak of global health concern

(2020) Chen Wang et al.   LANCET

A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

“Review article: COVID-19 and liver disease - what we know on 1st May 2020”

(2020) Isabel Garrido et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

(2020) Giovanni Targher et al.   GUT

Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations

(2020) George Lau et al.   Hepatology International

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

(2020) Safiya Richardson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Metabolic associated fatty liver disease increases COVID‐19 disease severity in non‐diabetic patients

(2020) Feng Gao et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

(2020) Yijin Wang et al.   JOURNAL OF HEPATOLOGY

High Mortality Rates for SARS-CoV-2 Infection in Patients with Pre-existing Chronic Liver Disease and Cirrhosis: Preliminary Results from an International Registry

(2020) Andrew M. Moon et al.   JOURNAL OF HEPATOLOGY

Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis

(2020) Yu-Jie Zhou et al.   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study

(2020) Dong Ji et al.   JOURNAL OF HEPATOLOGY

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

(2020) Lennard Y W Lee et al.   LANCET

Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis

(2020) Alessandro Mantovani et al.   LIVER INTERNATIONAL

Liver injury during highly pathogenic human coronavirus infections

(2020) Ling Xu et al.   LIVER INTERNATIONAL

Clinical characteristics of non‐ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study

(2020) Hansheng Xie et al.   LIVER INTERNATIONAL

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

(2020) Tao Chen et al.   BMJ-British Medical Journal

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

(2020) Jing Liu et al.   EBioMedicine

Liver injury in COVID-19: management and challenges

(2020) Chao Zhang et al.   Lancet Gastroenterology & Hepatology

The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan

(2020) Haijun Huang et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19

(2020) Steffen Jockusch et al.   ANTIVIRAL RESEARCH

Clinical Features and Outcomes of Coronavirus Disease 2019 (COVID-19) Patients With Chronic Hepatitis B Virus Infection

(2020) Bin Zhang et al.   Clinical Gastroenterology and Hepatology

Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection

(2020) Xiaojing Zou et al.   Clinical Gastroenterology and Hepatology

Clinical Features of COVID-19-Related Liver Functional Abnormality

(2020) Zhenyu Fan et al.   Clinical Gastroenterology and Hepatology

Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?

(2020) Chimaobi M Anugwom et al.   CLINICAL INFECTIOUS DISEASES

COVID‐19 and nonalcoholic fatty liver disease: two intersecting pandemics

(2020) Piero Portincasa et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort

(2020) Jasmohan S Bajaj et al.   GUT

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

(2020) Shiv Kumar Sarin et al.   Hepatology International

Effect of COVID-19 on patients with compensated chronic liver diseases

(2020) Dong Ji et al.   Hepatology International

Longitudinal Changes of Liver Function and Hepatitis B Reactivation in COVID‐19 Patients with Pre‐existing Chronic HBV Infection

(2020) Jiaye Liu et al.   HEPATOLOGY RESEARCH

SARS-CoV2 in patients on antiviral HBV and HCV therapy in Spain

(2020) Sabela Lens et al.   JOURNAL OF HEPATOLOGY

High rates of 30-day mortality in patients with cirrhosis and COVID-19

(2020) Massimo Iavarone et al.   JOURNAL OF HEPATOLOGY

A case series of COVID‐19 patients with chronic hepatitis B virus infection

(2020) Yang Li et al.   JOURNAL OF MEDICAL VIROLOGY

Clinical characteristics in patients with SARS‐CoV‐2/HBV co‐infection

(2020) Liping Chen et al.   JOURNAL OF VIRAL HEPATITIS

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study

(2020) Abdo A. Elfiky   LIFE SCIENCES

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

(2020) Jérôme Hadjadj et al.   SCIENCE

Analysis of liver injury factors in 332 patients with COVID-19 in Shanghai, China

(2020) Hongying Guo et al.   Aging-US

Clinical Characteristics of COVID-19 Patients With Pre-existing Hepatitis B Virus Infection

(2020) Qing He et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study

(2020) Donghee Kim et al.   Clinical Gastroenterology and Hepatology

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study

(2020) Thomas Marjot et al.   JOURNAL OF HEPATOLOGY

Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy

(2020) Sergio Rodríguez‐Tajes et al.   JOURNAL OF VIRAL HEPATITIS

Epidemiological and clinical characteristics of 70 cases of coronavirus disease and concomitant hepatitis B virus infection: A multicentre descriptive study

(2020) Jian Wu et al.   JOURNAL OF VIRAL HEPATITIS

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

(2020) Qian Zhang et al.   SCIENCE

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

(2020) Paul Bastard et al.   SCIENCE

HIV and Human Coronavirus Coinfections: A Historical Perspective

(2020) Palesa Makoti et al.   Viruses-Basel

Hepatitis B virus persistence and reactivation

(2020) Yu Shi et al.   BMJ-British Medical Journal

Clinical Characteristics of Hospitalized Patients with SARS-CoV-2 and Hepatitis B Virus Co-infection

(2020) Xiaoping Chen et al.   VIROLOGICA SINICA

Countdown to 2030: eliminating hepatitis B disease, China

(2019) Jue Liu et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

The Commensal Microbiota and Viral Infection: A Comprehensive Review

(2019) Na Li et al.   Frontiers in Immunology

Risk of hepatitis B surface antigen seroreversion after corticosteroid in patients with previous hepatitis B virus exposure

(2019) Grace Lai-Hung Wong et al.   JOURNAL OF HEPATOLOGY

Hepatitis B virus infection

(2018) Man-Fung Yuen et al.   Nature Reviews Disease Primers

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Gregory A Roth et al.   LANCET

Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions

(2017) Rohit Loomba et al.   GASTROENTEROLOGY

Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation

(2017) Le-Feng Chen et al.   International Journal of Rheumatic Diseases

Seroepidemiology of hepatitis B virus infection in 2 million men aged 21–49 years in rural China: a population-based, cross-sectional study

(2016) Jue Liu et al.   LANCET INFECTIOUS DISEASES

Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells

(2013) Barbara Rehermann   NATURE MEDICINE